We’ve got a joint account

We’ve got a joint account balmermedical.ch The Israel-based company said the U.S. Food and DrugAdministration lifted its clinical hold on a mid-stage trial ofthe company’s experimental drug for muscle pain. Pluristem saidthe FDA allowed it to go ahead with the study, saying thatPluristem had addressed all issues related to the hold.